These next-generation formulations are expected to launch within 18 months and have the potential to provide superior cryopreservation outcomes for certain biological constructs, utilize lower ...

As a pioneer of ovarian tissue cryopreservation and transplantation in China, Ruan is not only dedicated to advancing the technology but also hopes to ensure that patients are fully informed about ...

The formation of extracellular ice during cryopreservation is known to be a hazard to structured organs and tissues, and conventional cryopreservation strategies have proved unsatisfactory.

PanTHERA has completed the development and launched its first-generation IRI technology, while progressing development on its next generation molecules designed to be combined with BioLife's line of ...